Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.
Latest
Popular
Free webinar: Telepathology: is there added value in LMICs?
Free webinar: Telepathology: is there added value in LMICs?

AORTIC and the benefits of coordination between different US NCI-designated cancer centres in Kenya

Dr Lisa Stevens - National Cancer Institute, Bethesda, USA
AORTIC and the benefits of coordination between different US NCI-designated cancer centres in Kenya ( Dr Lisa Stevens - National Cancer Institute, Bethesda, USA )
5 May 2014

Microenvironment of tumours key to cancer's progression

Dr Rakesh Jain - Harvard Medical School, Boston, USA
Microenvironment of tumours key to cancer's progression ( Dr Rakesh Jain - Harvard Medical School, Boston, USA )
2 May 2014

Subset of breast cancer patients found to benefit from neratinib in latest trial

Dr John W. Park - University of California San Francisco, San Francisco, USA
Subset of breast cancer patients found to benefit from neratinib in latest trial ( Dr John W. Park - University of California San Francisco, San Francisco, USA )
1 May 2014

New antibody-drug conjugate shows early promise against all forms of melanoma

Dr Jeffrey Infante - Tennessee Oncology, Nashville, USA
New antibody-drug conjugate shows early promise against all forms of melanoma ( Dr Jeffrey Infante - Tennessee Oncology, Nashville, USA )
1 May 2014

Phase II trial shows dacomitinib benefits a subgroup of patients with head and neck cancer

Dr Byoung Chul Cho - Yonsei University College of Medicine, Seoul, Republic of Korea
Phase II trial shows dacomitinib benefits a subgroup of patients with head and neck cancer ( Dr Byoung Chul Cho - Yonsei University College of Medicine, Seoul, Republic of Korea )
1 May 2014

Phase I trial shows the benefits of OTX015 in treating blood cancer

Dr Esteban Cvitkovic - Oncoethix, Lausanne, Switzerland
Phase I trial shows the benefits of OTX015 in treating blood cancer ( Dr Esteban Cvitkovic - Oncoethix, Lausanne, Switzerland )
1 May 2014

"Exciting" implications of bemacyclib study in the treatment of breast cancer

Dr Amita Patnaik - South Texas Accelerated Research Therapeutics, San Antonio, USA
"Exciting" implications of bemacyclib study in the treatment of breast cancer ( Dr Amita Patnaik - South Texas Accelerated Research Therapeutics, San Antonio, USA )
1 May 2014

Immunotherapy in melanoma

Dr Adil I. Daud - University of California San Francisco School of Medicine, San Francisco, USA
Immunotherapy in melanoma ( Dr Adil I. Daud - University of California San Francisco School of Medicine, San Francisco, USA )
1 May 2014

Role of AORTIC in dealing with rising cancer rates in Africa

North American Vice president of AORTIC
Role of AORTIC in dealing with rising cancer rates in Africa ( North American Vice president of AORTIC )
1 May 2014

AG-221 shows clinical activity in acute myeloid leukaemia

Dr Eytan Stein - Memorial Sloan Kettering Cancer Center, New York, USA
AG-221 shows clinical activity in acute myeloid leukaemia ( Dr Eytan Stein - Memorial Sloan Kettering Cancer Center, New York, USA )
1 May 2014

Impact of the liver environment upon the efficacy of induction therapy

Dr Frederic Bibeau - Institut regional du Cancer, Montpellier, France
Impact of the liver environment upon the efficacy of induction therapy ( Dr Frederic Bibeau - Institut regional du Cancer, Montpellier, France )
1 May 2014

Study identifies new strategy to overcome breast cancer resistance to HER2-targeted therapies

Dr Joan Garrett - Vanderbilt University Medical Center, Nashville, USA
Study identifies new strategy to overcome breast cancer resistance to HER2-targeted therapies ( Dr Joan Garrett - Vanderbilt University Medical Center, Nashville, USA )
1 May 2014

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation